What we can learn from the selective manipulation of dopaminergic receptors about the pathogenesis and treatment of hypertension?

Current Opinion in Nephrology and Hypertension

Volumn 5, Issue 5, 1996, Pages 447-451

  Jose, Pedro A ^a   Felder, Robin A ^b  

^a Children's Medical Center   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BROMOCRIPTINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ECOPIPAM; EMONAPRIDE; ETICLOPRIDE; FENOLDOPAM; NAFADOTRIDE; QUINPIROLE; ROTIGOTINE; SULPIRIDE;

HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029905204     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199609000-00012     Document Type: Review

References (62)

1. Bianchi G, Fox U, DiFrancesco GF, Giovanetti AM, Pagetti D: Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive and normotensive rats. Clin Sd Mol Med 1974, 47:435-448.
2. Rettig R, Folberth C, Stauss H, Kopf D, Waldherr R, Unger T: Role of the kidney in primary hypertension: a renal transplantation in rats. Am J Physiol 1990, 258:F606-F611.
3. Morgan DA, DiBona GF, Mark AL: Effects of interstrain renal transplantation on NaCl-induced hypertension in Dahl rats. Hypertension 1990, 15:436-442.
4. Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, Diethel AG: Remission of essential hypertension after renal transplantation. N Engl J Med 1983, 309:1009-1015.
5. Heller J, Schubert G, Havlickova J, Thurau K: The role of the kidney in the development of hypertension: a transplantation study in the Prague hypertensive rat. Pflügers Arch 1993, 425:208-212.
6. Jose PA, Eisner GM, Drago J, Carey RM, Felder RA: Dopamine receptor signaling defects in spontaneous hypertension. Am J Hypertens 1996, 9:400-405. A dopamine prodrug, gludopa, is reported to increase urinary dopamine to the same extent in SHR and its normotensive control strain (the WKY rat) but to increase sodium excretion 4.9-fold in WKY rats and only 3.1-fold in SHR. The NHE activity in renal proximal tubular brush-border membranes is decreased by gludopa in WKY rats but not in SHR.
7. Jose PA, Raymond JR, Bates MD, Aperia A, Felder RA, Carey RM: The renal dopamine receptors. J Am Soc Nephrol 1992, 2:1265-1278.
8. Goldstein DS, Stull R, Eisenhofer G, Gill JR Jr: Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans. Clin Sci (Colch) 1989, 76:517-522.
9. Hegde SS, Jadhav AL, Lokhandwala MF: Role of kidney dopamine in the natriuretic response to volume expansion in rats. Hypertension 1989, 13:826-834.
10. Kuchel OG, Kuchel GA: Peripheral dopamine in pathophysiology of hypertension: interaction with aging and lifestyle. Hypertension 1991, 18:709-721.
11. Seeman P, Van Tol HHM: Dopamine receptor pharmacology. Trends Pharmacol Sci 1994, 15:264-270.
12. Gingrich JA, Caron MG: Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 1993, 16:299-321.
13. Civelli O, Bunzow JR, Grandy DK: Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 1993, 3:281-307.
14. Sibley DR, Monsma FJ Jr: Molecular biology of dopamine receptors. Trends Pharmacol Sci 1992, 13:61-69.
15. 1-like receptors from Gallus domesticus. J Biol Chem 1995, 270:4005-4012.
16. Watson S, Girdlestone D: 1996 Receptor and ion channel nomenclature supplement. Trends Pharmacol Sci 1996, 17:1-81. This is an outstanding compilation of pharmacological and molecular biological characteristics of surface membrane receptors.
17. +ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect Am J Physiol 1988, 254:F795-F801.
18. Sowers JR, Zemel MB, Zemel P, Beck FWJ, Walsh MF, Zawada ET: Salt sensitivity in blacks: salt intake and natriuretic substances. Hypertension 1988, 12:485-490.
19. Gill JR Jr, Grossman E, Goldstein DS: High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension. Hypertension 1991, 18:614-621.
20. Gill JR Jr, Gullner HG, Lake CR, Lakatua DJ, Lan G: Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension 1988, 11:312-319.
21. Gordon MS, Steunkel CA, Conlin PR, Hollenberg NK, Williams GH: The role of dopamine in non-modulating hypertension. J Clin Endocrinol Metab 1989, 69:426-432.
22. Saito I, Takeshita E, Saruta T, Nagano S, Sekihara T: Urinary dopamine excretion in normotensive subjects with and without family history of hypertension. J Hypertens 1986, 4:57-60.
23. Saito I, Itsuji S, Takeshita E, Kawabe H, Nishino M, Winai H, Hasegawa C, Saruta T, Nagano S, Sekihara T: Increased urinary dopamine excretion in young patients with essential hypertension. Clin Exp Hypertens 1994, 16:29-39.
24. Clark BA, Rosa RM, Epstein FH, Young JB, Landsberg L: Altered dopaminergic responses in hypertension. Hypertension 1992, 19:589-594.
25. Carey RM, O'Connell DP, Felder RA: Renal dopaminergic mechanisms in salt sensitive hypertension. 5th International Conference on Peripheral Dopamine, Kyoto, Japan, 1994:36.
26. Kinoshita S, Sidhu A, Felder RA: Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 1989, 84:1849-1856.
27. Felder RA, Kinoshita S, Ohbu K, Mouradian MM, Sibley DR, Monsma FJ Jr, Minowa T, Minowa MT, Canessa LM, Jose PA: Renal dopamine-1 receptor mRNA and organ specificity of the dopamine-1 receptor/adenylyl cyclase coupling defect in the spontaneously hypertensive rat. Am J Physiol 1993, 264:R726-R732.
28. Horiuchi A, Albrecht F, Eisner GM, Jose PA, Felder RA: Renal dopamine receptors and pre- and post-cAMP mediated sodium transport defect in the spontaneously hypertensive rat. Am J Physiol 1992, 263:F1105-F1111.
29. Chen CJ, Vyas SJ, Eichberg J, Lokhandwala, MF: Diminished phospholipase C activation by dopamine in spontaneously hypertensive rats. Hypertension 1992, 19:102-108.
30. Chen CJ, Beach RE, Lokhandwala MF: Dopamine fails to inhibit renal tubular sodium pump in spontaneously hypertensive rats. Hypertension 1993, 21:364-372.
31. Albrecht FE, Robillard JE, Eisner GM, Jose PA: Receptor and G-protein regulation of the renal apical sodium/hydrogen exchanger (NHE) in genetic hypertension [Abstract]. Pediatr Res 1995, 37:358A.
32. + exchanger in spontaneously hypertensive rats. Am J Physiol 1991, 261:F526-F536.
33. +-ATPaSe by G proteins in spontaneously hypertensive rats. Am J Physiol 1994, 267:F1069-F1075.
34. 1 receptor/G-protein/effector enzyme coupling defect reported in the renal proximal tubules of SHR is also present in renal resistance vessels.
35. Ohbu K, Felder RA: Nephron segment specificity of dopamine receptor/adenylyl cyclase defect in spontaneous hypertension. Am J Physiol 1993, 264:F274-F279.
36. +-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 1993, 21:767-771.
37. Debska-Slizien A, Ho P, Drangova R, Baines AD: Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys. J Am Soc Nephrol 1994, 5:1125-1132.
38. 1A receptor gene produces hypertension in mice.
39. 1B dopamine receptor mRNAs in opossum kidney and brain. Mol Pharmacol 1993, 44:918-925.
40. 1B dopamine receptors in rat kidney. Soc Neurosci Abstr 1993, 75.
41. von Zastrow M, Kobilka BK: Antagonist-dependent and -independent steps in the mechanism of adrenergic receptor internalization. J Biol Chem 1994, 269:18448-18452.
42. 1A receptor in renal proximal tubule cells in spontaneous hypertension [Abstract]. Pediatr Res 1996, 39:372A.
43. Deng AY, Dene H, Pravenec M, Rapp JP: Genetic mapping of two new blood pressure quantitative loci in the rat by genotyping endothelin system genes. J Clin Invest 1994, 93:2701-2709.
44. 1A polymorphism is reported to cosegregate with cardiac mass but not hypertension in genetic hypertension in congenic rats.
45. Shigetomi S, Ueno S, Kono H, Tosaki H, Suenaga K, Hashimoto S, Fukuchi S: Role of dopamine receptor in the pathogenesis of hypertension after sodium loading. Folia Endocrinol 1986, 62:26-33.
46. Yoshimura M, Kambara S, Takahashi H, Okabayashi H, Ijichi H: Involvement of dopamine in the development of hypertension in spontaneously hypertensive rats; effect of carbidopa, inhibitor of peripheral dopa decarboxylase. Clin Exp Hypertens [A] 1987, 9:1585-1599.
47. 1R) receptor expression in the proximal tubule [Abstract]. J Am Soc Nephrol 1995, 6:734.
48. Thomas D, Harris PJ, Morgan TO: Age-related changes in angiotensin II-stimulated proximal tubule fluid reabsorption in the spontaneously hypertensive rat J Hypertens 1988, 6(suppl 4):S449-S451.
49. Matsushima Y, Kawamura M, Akabane S, Imanishi M, Kuramochi M, Ito K, Omae T: Increases in angiotensin II content and tubular angiotensin II receptors in prehypertensive spontaneously hypertensive rat J Hypertens 1988, 6:791-796.
50. Siragy HM, Felder RA, Howell NL, Chevalier NL, Peach MJ, Carey RM: Evidence that dopamine-2 mechanisms control renal function. Am J Physiol 1990, 259:F793-F800.
51. 2 dopamine receptor stimulation in the conscious dog. Am J Physiol 1992, 262:F932-F938.
52. 2 blockade on renal function under varied sodium intake. J Clin Endocrinol Metab 1994, 78:1079-1084.
53. 2 receptor. Eur J Pharmacol 1992, 225:331-337.
54. 2 dopamine receptors. Mol Pharmacol 1994, 45:51-60.
55. Seeman P: Receptor tables, vol 2: Drug dissociation constants for neuroreceptors and transporters. Toronto: SZ Research; 1993.
56. 4 dopamine receptors in fibroblasts and dopaminergic cell lines. J Pharmacol Exp Ther 1994, 268:495-502.
57. 2long receptors heterologously expressed in murine fibroblasts stimulate sodium pump activity by decreasing adenylyl cyclase activity.
58. 2 receptors. Am J Physiol 1990, 259:F924-F928.
59. 3) as a target for neuroleptics. Nature 1990, 347:146-151.
60. Yao L, Yamaguchi I, Ozono R, Walk SF, McGrath B, Dagli H, Carey RM, Jose PA, Felder RA: Dopamine receptor (DAR) subtype expression and function in rat juxtaglomerular (JG) cells [Abstract]. Pediatr Res 1996, 39:372A.
61. Worth DP, Harvey JN, Brown J, Worral A, Lee MR: Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous γ-L-glutamyl-L-dopa. Br J Clin Pharmacol 1986, 21:497-502.
62. 3 dopamine receptors [Abstract]. J Invest Med 1996, 44:307A.